Related Experiment Videos
[Low dose methotrexate therapy in rheumatoid arthritis]
T Shinozawa1, H Akama, Y Matsushita
1Department of Internal Medicine, School of Medicine, Keio University, Tokyo.
Ryumachi. [Rheumatism]
|June 1, 1990
Summary
Low-dose methotrexate (MTX) significantly improved clinical symptoms and slowed radiographic progression in refractory rheumatoid arthritis patients. While generally safe, some adverse events led to treatment withdrawal.
Area of Science:
- Rheumatology
- Pharmacology